• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

by Fred Pennic 09/15/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

What You Should Know:

– XRHealth has just received a patent for its approach to incorporate biofeedback from devices such as an Apple watch into its remote healthcare therapy platform that utilizes virtual/artificial reality (VR/AR).

– XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical-grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat.


XRHealth, the leader in extended reality therapeutic applications, announces that they received a patent to utilize approaches that incorporate biofeedback into their extended reality therapy.  U.S. Patent No. 16/067,480, entitled “A Therapy and Physical Training Device,” was issued on September 15, 2020. 

These novel approaches enable VR/AR therapy to address patient pain based on biofeedback such us heart rate variability, EEG, galvanic skin response, and other critical responses while patients are using the VR/AR devices.  Solutions that incorporate biofeedback allow patient treatment to be customized according to their unique needs and better inform clinicians on how patients are responding to therapy.

VR/AR therapy Integration with Apple Watch

XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat. XRHealth will use the output measurements of the Apple Watch to detect pain, which will modify VR/AR therapy treatment for patients based on the pain that they feel during the sessions.

“The newly awarded patent reflects XRHealth’s commitment to creating the most sophisticated form of therapy that responds to patient physical needs in real-time,” said Eran Orr, CEO of XRHealth. “Virtual Reality therapy that incorporates biofeedback will enhance and personalize the patient experience and provide clinicians with critical insights.” 

XRHealth created the first virtual reality telehealth clinic in the world that treats multiple conditions like anxiety & stress, cognitive impairment, pain management, Parkinson’s, and multiple sclerosis. XRHealth provides doctors with patient data that allows them to monitor and treat them in real-time.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: apple, Apple Watch, Augmented Reality, FDA, Heart, Pain Management, Patient Experience, Virtual Reality, XRHealth

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

HHS Reverses 2024 Tech Reorganization: Why HHS Just Stripped AI and Cyber Operations Out of the ONC

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Microsoft Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Microsoft Launches Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

RadNet Subsidiary DeepHealth Acquires French Radiology AI Leader Gleamer

RadNet’s $269M AI Play: DeepHealth Acquires French AI Gleamer

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |